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Ischemic postconditioning (IPost) and erythropoietin (EPO) have been shown to
attenuate myocardial reperfusion injury using similar signaling pathways. The aim of
this study was to examine whether EPO is as effective as IPost in decreasing
postischemic myocardial injury in both Langendorff-isolated-heart and in vivo
ischemia-reperfusion rat models. Rat hearts were subjected to 25 min ischemia,
followed by 30 min or 2 h of reperfusion in the isolated-heart study. Rats underwent
45 min ischemia, followed by 24 h of reperfusion in the in vivo study. In both studies,
the control group (n = 12; ischemia-reperfusion only) was compared with IPost (n =
16; 3 cycles of 10 s reperfusion/10 s ischemia) and EPO (n = 12; 1,000 IU/kg) at the
onset of reperfusion. The following resulted. First, in the isolated hearts, IPost or
EPO significantly improved postischemic recovery of left ventricular developed
pressure. EPO induced better left ventricular developed pressure than IPost at 30
min of reperfusion (73.18 ± 10.23 vs. 48.11 ± 7.92 mmHg, P < 0.05). After 2 h of
reperfusion, the infarct size was significantly lower in EPO-treated hearts compared
with IPost and control hearts (14.36 ± 0.60%, 19.11 ± 0.84%, and 36.21 ± 4.20% of
the left ventricle, respectively; P < 0.05). GSK-3β phosphorylation, at 30 min of
reperfusion, was significantly higher with EPO compared with IPost hearts.
Phosphatidylinositol 3-kinase and ERK1/2 inhibitors abolished both EPO- and IPost-
mediated cardioprotection. Second, in vivo, IPost and EPO induced an infarct size
reduction compared with control (40.5 ± 3.6% and 28.9 ± 3.1%, respectively, vs.
53.7 ± 4.3% of the area at risk; P < 0.05). Again, EPO decreased significantly more
infarct size and transmurality than IPost (P < 0.05). In conclusion, with the use of
our protocols, EPO showed better protective effects than IPost against reperfusion
injury through higher phosphorylation of GSK-3β.
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